Activation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells (vol 29, pg 1676, 2022)Ilan Zaffran,Nadine Landolina,Pratibha Gaur,Tihana Lenac Rovis,Stipan Jonjic,Ofer Mandelboim,Bernhard B. Singer,Francesca Levi-SchafferCANCER GENE THERAPY(2023)引用 0|浏览7暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要